
Sign up to save your podcasts
Or
It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.
4.7
9292 ratings
It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.
133 Listeners
314 Listeners
490 Listeners
690 Listeners
278 Listeners
256 Listeners
3,319 Listeners
90 Listeners
1,114 Listeners
191 Listeners
512 Listeners
350 Listeners
248 Listeners
365 Listeners
316 Listeners